Literature DB >> 10878616

Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution.

M S Pepper1, D Baetens, S J Mandriota, C Di Sanza, S Oikemus, T F Lane, J V Soriano, R Montesano, M L Iruela-Arispe.   

Abstract

Vascular endothelial growth factors (VEGFs) are endothelial cell-specific mitogens with potent angiogenic and vascular permeability-inducing properties. VEGF, VEGF-C, and VEGFRs -1, -2, and -3 were found to be expressed in post-pubertal (virgin) rodent mammary glands. VEGF was increased during pregnancy (5-fold) and lactation (15-19-fold). VEGF-C was moderately increased during pregnancy and lactation (2- and 3-fold respectively). VEGF levels were reduced by approximately 75% in cleared mouse mammary glands devoid of epithelial components, demonstrating that although the epithelial component is the major source of VEGF, approximately 25% is derived from stroma. This was confirmed by the findings (a) that VEGF transcripts were expressed predominantly in ductal and alveolar epithelial cells, and (b) that VEGF protein was localized to ductal epithelial cells as well as to the stromal compartment including vascular structures. VEGF was detected in human milk. Finally, transcripts for VEGFRs -2 and -3 were increased 2-3-fold during pregnancy, VEGFRs -1, -2 and -3 were increased 2-4-fold during lactation, and VEGFRs -2 and -3 were decreased by 20-50% during involution. These results point to a causal role for the VEGF ligand-receptor pairs in pregnancy-associated angiogenesis in the mammary gland, and suggest that they may also regulate vascular permeability during lactation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10878616     DOI: 10.1002/1097-0177(200007)218:3<507::AID-DVDY1012>3.0.CO;2-5

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  21 in total

Review 1.  The mammary gland vasculature revisited.

Authors:  Anne-Catherine Andres; Valentin Djonov
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-08-14       Impact factor: 2.673

2.  Conditional knockout of fibronectin abrogates mouse mammary gland lobuloalveolar differentiation.

Authors:  Keyi Liu; Le Cheng; Andrea Flesken-Nikitin; Lynn Huang; Alexander Y Nikitin; Bendicht U Pauli
Journal:  Dev Biol       Date:  2010-08-10       Impact factor: 3.582

3.  Neuropilin-1 participates in wound angiogenesis.

Authors:  Annette M Matthies; Quentin E H Low; Mark W Lingen; Luisa A DiPietro
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

4.  Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in canine simple mammary gland adenocarcinomas.

Authors:  Ahmad N Al-Dissi; Deborah M Haines; Baljit Singh; Beverly A Kidney
Journal:  Can Vet J       Date:  2010-10       Impact factor: 1.008

5.  Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer.

Authors:  Traci R Lyons; Virginia F Borges; Courtney B Betts; Qiuchen Guo; Puja Kapoor; Holly A Martinson; Sonali Jindal; Pepper Schedin
Journal:  J Clin Invest       Date:  2014-08-18       Impact factor: 14.808

Review 6.  Vascular endothelial growth factors and vascular permeability.

Authors:  David O Bates
Journal:  Cardiovasc Res       Date:  2010-04-16       Impact factor: 10.787

7.  Altered fracture repair in the absence of MMP9.

Authors:  Céline Colnot; Zachary Thompson; Theodore Miclau; Zena Werb; Jill A Helms
Journal:  Development       Date:  2003-09       Impact factor: 6.868

8.  Vascular Robo4 restricts proangiogenic VEGF signaling in breast.

Authors:  Rebecca Marlow; Mikhail Binnewies; Lise K Sorensen; Stefanie D Monica; Phyllis Strickland; E Camilla Forsberg; Dean Y Li; Lindsay Hinck
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

9.  Ovarian VEGF(165)b expression regulates follicular development, corpus luteum function and fertility.

Authors:  Y Qiu; M Seager; A Osman; J Castle-Miller; H Bevan; D J Tortonese; D Murphy; S J Harper; H M Fraser; L F Donaldson; D O Bates
Journal:  Reproduction       Date:  2012-01-09       Impact factor: 3.906

10.  The anti-angiogenic isoforms of VEGF in health and disease.

Authors:  Yan Qiu; Coralie Hoareau-Aveilla; Sebastian Oltean; Steven J Harper; David O Bates
Journal:  Biochem Soc Trans       Date:  2009-12       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.